Cost and Utilization Outcomes of Opioid-Dependence TreatmentsByOnur Baser, PhD, MS,Mady Chalk, PhD,David A. Fiellin, MD,David R. Gastfriend, MDJune 17th 2011
Alcohol Dependence Treatments: Comprehensive Healthcare Costs, Utilization Outcomes, and Pharmacotherapy PersistenceByOnur Baser, PhD, MS,Mady Chalk, PhD,Richard Rawson, PhD,David R. Gastfriend, MDJune 17th 2011
Extended-Release Naltrexone for Alcohol Dependence: Persistence and Healthcare Costs and UtilizationByWilliam C. Bryson, MD, MPH,K. John McConnell, PhD,P. Todd Korthuis, MD, MPH,Dennis McCarty, PhDJune 17th 2011
Utilization Patterns of Extended-Release Naltrexone for Alcohol DependenceBySaira Jan, PharmD,Patrick Gill, RPh,Ami S. Borawala, PharmDJune 17th 2011
Economic Considerations for the Treatment of Opioid and Alcohol Dependence: A Managed Care PerspectiveByJeffrey D. Dunn, PharmD, MBA, Formulary,Contract Manager, SelectHealthJune 16th 2011
Participating Faculty: Economic Considerations for the Treatment of Opioid and Alcohol DependenceByJune 16th 2011
